chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenitis, Psoriasis, SARS-CoV-2 test
Clinical narrative: My left lymph node inflamed for about two weeks.; I got a flare up of psoriasis in my right knee; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 30Apr2021 at 18:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 08Apr2021 at 11:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. On 02May2021 at 06:00, during the following week the patient felt left lymph node inflamed for about two weeks. On an unknown date in 2021, about a week ago, the patient got a flare up of psoriasis in right knee and never had before. Since the vaccination, the patient had been tested for COVID-19. On 12Jun2021, the patient underwent lab test and procedure which included PCR test and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of event lymph node inflamed and flare up of psoriasis in right knee was not recovered at the time of this report.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Food craving, Hunger, Vaccination site pain, Vaccination site swelling, Weight increased
Clinical narrative: My initial side effects were relatively common. Such as injection site soreness, swelling for a few days following the vaccination.; My initial side effects were relatively common. Such as injection site soreness, swelling for a few days following the vaccination.; I have had incontrollable hunger, cravings.; I have had incontrollable hunger, cravings.; Since the vaccination I have gained 8lbs.; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on an unknown date in Jul2021 as a single dose for COVID-19 immunisation. Medical history included permanent sterilization (female sterilization), latex allergy and penicillin allergy. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Jul2021, the patient experienced initial side effects which were relatively common such as injection site soreness, swelling for a few days following the vaccination. 72 hours after the vaccination the patient had uncontrollable hunger, cravings. The patient was not pregnant. (Permanent sterilization). Since the vaccination the patient had gained 8 lbs. It was so severe that the patient thought that it should be reported. Perhaps other people were experiencing the same side effect. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event vaccination site soreness, swelling, uncontrollable hunger cravings and weight gain were unknown at the time of this report.   The lot number for BNT162b2, were not provided and will be requested during follow up.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Migraine, Pain
Clinical narrative: Migraines; Persistent cough; Aches/pain for 48 hours following administration; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0188) via an unspecified route of administration on 18May2021 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included finasteride (PROPECIA) for unknown indication started on an unknown date. The patient previously took amoxicillin (MANUFACTURER UNKNOWN) on an unknown date and experienced allergy. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration on 27Apr2021 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18May2021, the patient experienced aches/pain for 48 hours following administration. On 28May2021, the patient experienced migraines, persistent cough lasting 6 weeks post administration. Therapeutic measures were taken as a result of cough and included treatment with cough suppressant. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event aches/pain was recovered on an unknown date in 20May2021 after the duration of 48 hours and the events migraines and persistent cough was not recovered at the time of this report.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Fibrin D dimer, Fibrin D dimer increased, Heart rate, Heart rate increased
Clinical narrative: Chest pain; High heart rate; positive d dimer elevation; This is a spontaneous report from a contactable consumer or other non hcp. A 28-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 29Jun2021 17:30 (Age at vaccination 28 years old) (Batch/Lot Number: Ewo180) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included drug hypersensitivity from an unknown date and unknown if ongoing known allergies: Penicillin. The patient's concomitant medications were not reported. on 30Jun2021 21:00 the patient experienced chest pain High heart rate, positive d dimer elevation.The patient underwent lab tests and procedures which included fibrin d dimer: elevation   on 30Jun2021, heart rate: high on 30Jun2021. Outcome of the events was not recovered.  Follow-up (30Jul2021 & 05Aug2021): This is a follow-up spontaneous report from a contactable consumer. This consumer reported in response to HCP letter sent via telephonic follow-up activity that includes Follow-up attempts are completed. No further information is expected
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Muscular weakness, Neck pain, Vertigo
Clinical narrative: shoulder pain; Neck pain; vertigo; fatigue; muscle weakness; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12May2021 at 09:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient previously took montelukast sodium(SINGULAIR) on an unknown date for unknown indication and experienced drug allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included levocetirizine dihydrochloride (XYZAL), fluticasone propionate (FLONASE) and nortriptyline hydrochloride (NORTRIPTYLINE); all on an unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12May2021 at 10:00 the patient experienced Neck and shoulder pain, vertigo, fatigue, muscle weakness. The event resulted in doctor or other healthcare professional office/clinic visit. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event Neck and shoulder pain, vertigo, fatigue, muscle weakness was not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Confusional state, Depression, Disturbance in attention, Mental fatigue
Clinical narrative: Brain fog; Mental fatigue; Lack of concentration; Mild tremors in hands; Anxiety; Depression; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 17Mar2021 at 13:00 (at the age of 31-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 07Apr2021 at 13:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune symptoms which subsided before vaccination. The patient was not allergic to medications, food, or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021, the patient experienced brain fog, mental fatigue, lack of concentration, mild tremors in hands, anxiety and depression. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department visit or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events brain fog, mental fatigue, lack of concentration, mild tremors in hands, anxiety and depression were not resolved at the time of report.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Brain fog; Mental fatigue; Lack of concentration; Mild tremors in hands; Anxiety; Depression; This is a spontaneous report from a contactable consumer, the patient. A 31-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 17Mar2021 at 13:00 (at the age of 31-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 07Apr2021 at 13:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Medical history included autoimmune symptoms which subsided before vaccination. The patient was not allergic to medications, food, or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Mar2021, the patient experienced brain fog, mental fatigue, lack of concentration, mild tremors in hands, anxiety and depression. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department visit or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events brain fog, mental fatigue, lack of concentration, mild tremors in hands, anxiety and depression were not resolved at the time of report.
Sex: F
Vaccine: COVID19
Symptoms: Postmenopausal haemorrhage, Tremor
Clinical narrative: developed post-menopausal bleeding.; developed unilateral tremors in her forearms when reaching out, and also in her knees when walking downstairs; This is a spontaneous report from a non-contactable consumer (patient). A 57-year-old female patient received BNT162B2 (PFIZER BIONTECH COVID-19 VACCINE, solution for injection) via an unspecified route of administration, administered in Arm Left on 20Apr2021 Lot number was not reported) as dose number unknown, single and on an unspecified date via an unspecified route of administration as dose number unknown, single; for COVID-19 immunisation. The patient's medical history was not reported. No COVID prior vaccination. The patient was not pregnant at the time of vaccination. There were no concomitant medications. No other vaccine was given in four weeks. No other medications in two weeks. The patient previously took fluoroquinolones and clarithromycin (BIAXIN) and experienced allergies. After being fully vaccinated, patient developed unilateral tremors in her forearms when reaching out, and also in her knees when walking downstairs. She also developed postmenopausal bleeding. These seem to be staying with the patient. No treatment was given for the events. Patient has not done a COVID tested post vaccination. The events resulted in doctor or other healthcare professional office/clinic visit. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Neck pain
Clinical narrative: Neck pain; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0198) via an unspecified route of administration in the left arm on 09Jul2021 at 11:00 (at the age of 69-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications included paracetamol (TYLENOL) and calcium/vitamin D 600 (MANUFACTURER UNKNOWN); both for unknown indication, from unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11Jul2021 at 10:00, the patient experienced neck pain. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event neck pain was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Decreased appetite, Dizziness, Dysmenorrhoea, Ear infection
Clinical narrative: Nausea; vomiting; Dizziness; Intense menstrual cramps/bleeding; Intense menstrual cramps/bleeding; swollen lymph nodes; Ear infection; loss of appetite; weight loss; fast heart rate; This is a spontaneous report from a contactable consumer reported for herself. A 21-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EP6935; Expiration date was not reported), intramuscular, administered in Arm Left on 18Mar2021 15:00 (at the age of 21-years-old) as DOSE 1, SINGLE for covid-19 immunisation at Pharmacy or Drug Store. Patient was not pregnant at the time of vaccination. Medical history included vertigo and ear pain (no surgeries unexplained occurrence) from 08Jan2020 and ongoing. Patient had no known allergies and other medical history. Family medical history relevant to AE included none. There were no concomitant medications. Other vaccines within 4 weeks prior to the COVID vaccine include none. The patient experienced nausea, vomiting, dizziness, intense menstrual cramps/bleeding, swollen lymph nodes, ear infection, loss of appetite, weight loss, fast heart rate on 18Mar2021. The patient underwent lab tests and procedures which included CT scan: nothing abnormal on Sep2020, heart rate: fast on 18Mar2021, sars-cov-2 test (COVID-19 test): negative on Oct2020, weight: loss on 18Mar2021. Therapeutic measures were taken as a result of ear infection which included antibiotics. AE resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/ department or urgent care. The events were not serious and seriousness criteria included none. Patient had nausea and vomiting for 3 days following vaccine, dizziness, intense menstrual cramps/ bleeding ever since vaccine, swollen lymph nodes for 3 months following vaccine, ear infection for 2 months immediately following vaccine, loss of appetite and weight loss, fast heart rate ever since vaccine received. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Clinical outcome of nausea, vomiting was recovered on 21Mar2021, ear infection recovered on unspecified date in May2021, swollen lymph nodes recovered on unspecified date in Jun2021, and outcome of other events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Heart rate increased, Heavy menstrual bleeding, Lymphadenopathy, Nausea
Clinical narrative: Nausea; vomiting; Dizziness; Intense menstrual cramps/bleeding; Intense menstrual cramps/bleeding; swollen lymph nodes; Ear infection; loss of appetite; weight loss; fast heart rate; This is a spontaneous report from a contactable consumer reported for herself. A 21-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EP6935; Expiration date was not reported), intramuscular, administered in Arm Left on 18Mar2021 15:00 (at the age of 21-years-old) as DOSE 1, SINGLE for covid-19 immunisation at Pharmacy or Drug Store. Patient was not pregnant at the time of vaccination. Medical history included vertigo and ear pain (no surgeries unexplained occurrence) from 08Jan2020 and ongoing. Patient had no known allergies and other medical history. Family medical history relevant to AE included none. There were no concomitant medications. Other vaccines within 4 weeks prior to the COVID vaccine include none. The patient experienced nausea, vomiting, dizziness, intense menstrual cramps/bleeding, swollen lymph nodes, ear infection, loss of appetite, weight loss, fast heart rate on 18Mar2021. The patient underwent lab tests and procedures which included CT scan: nothing abnormal on Sep2020, heart rate: fast on 18Mar2021, sars-cov-2 test (COVID-19 test): negative on Oct2020, weight: loss on 18Mar2021. Therapeutic measures were taken as a result of ear infection which included antibiotics. AE resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/ department or urgent care. The events were not serious and seriousness criteria included none. Patient had nausea and vomiting for 3 days following vaccine, dizziness, intense menstrual cramps/ bleeding ever since vaccine, swollen lymph nodes for 3 months following vaccine, ear infection for 2 months immediately following vaccine, loss of appetite and weight loss, fast heart rate ever since vaccine received. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Clinical outcome of nausea, vomiting was recovered on 21Mar2021, ear infection recovered on unspecified date in May2021, swollen lymph nodes recovered on unspecified date in Jun2021, and outcome of other events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Vomiting, Weight, Weight decreased
Clinical narrative: Nausea; vomiting; Dizziness; Intense menstrual cramps/bleeding; Intense menstrual cramps/bleeding; swollen lymph nodes; Ear infection; loss of appetite; weight loss; fast heart rate; This is a spontaneous report from a contactable consumer reported for herself. A 21-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot Number: EP6935; Expiration date was not reported), intramuscular, administered in Arm Left on 18Mar2021 15:00 (at the age of 21-years-old) as DOSE 1, SINGLE for covid-19 immunisation at Pharmacy or Drug Store. Patient was not pregnant at the time of vaccination. Medical history included vertigo and ear pain (no surgeries unexplained occurrence) from 08Jan2020 and ongoing. Patient had no known allergies and other medical history. Family medical history relevant to AE included none. There were no concomitant medications. Other vaccines within 4 weeks prior to the COVID vaccine include none. The patient experienced nausea, vomiting, dizziness, intense menstrual cramps/bleeding, swollen lymph nodes, ear infection, loss of appetite, weight loss, fast heart rate on 18Mar2021. The patient underwent lab tests and procedures which included CT scan: nothing abnormal on Sep2020, heart rate: fast on 18Mar2021, sars-cov-2 test (COVID-19 test): negative on Oct2020, weight: loss on 18Mar2021. Therapeutic measures were taken as a result of ear infection which included antibiotics. AE resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/ department or urgent care. The events were not serious and seriousness criteria included none. Patient had nausea and vomiting for 3 days following vaccine, dizziness, intense menstrual cramps/ bleeding ever since vaccine, swollen lymph nodes for 3 months following vaccine, ear infection for 2 months immediately following vaccine, loss of appetite and weight loss, fast heart rate ever since vaccine received. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Clinical outcome of nausea, vomiting was recovered on 21Mar2021, ear infection recovered on unspecified date in May2021, swollen lymph nodes recovered on unspecified date in Jun2021, and outcome of other events was unknown.  Follow-up attempts are completed. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chills, Fatigue, Headache, Pain in extremity
Clinical narrative: Headache; Chills; Fever; Back pain; Fatigue; Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0196) via an unspecified route of administration in the left arm on 26Jun2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included COVID-19 and back surgery on an unknown date in 2013. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included birth control (unspecified), multi-vitamin (unspecified), probiotic (unspecified) and calcium (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Jun2021, the patient experienced headache, chills, fever, back pain, fatigue and sore arm. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, chills, fever, back pain, fatigue and sore arm was resolved on an unknown date in 2021 at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Headache; Chills; Fever; Back pain; Fatigue; Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0196) via an unspecified route of administration in the left arm on 26Jun2021 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included COVID-19 and back surgery on an unknown date in 2013. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications included birth control (unspecified), multi-vitamin (unspecified), probiotic (unspecified) and calcium (MANUFACTURER UNKNOWN); all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Jun2021, the patient experienced headache, chills, fever, back pain, fatigue and sore arm. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, chills, fever, back pain, fatigue and sore arm was resolved on an unknown date in 2021 at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain, Pyrexia
Clinical narrative: Body aches; Fever; Joint pain; This is a spontaneous report from a non-contactable consumer, the patient. A 52-year-old female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration on 02Jul2021 at 17:30 (at the age of 52-years-old) as single dose for COVID-19 immunisation. Medical history included COVID-19 and artificial heart valve. The patient had known allergies to sulpha. Prior to the vaccination, the patient was diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Jul2021 at 11:00, the patient experienced body aches, fever and joint pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events body aches, fever and joint pain was unknown at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pain in extremity, Vaccination site movement impairment
Clinical narrative: She could not raise her left arm until now and she had piercing pain when she moved it. It was difficult even to dress up. The piercing pain woke her up at night a lot of times; she could not move her left arm upward/ She could not tie her hair and became so difficult to remove her clothes or put them on; but her arms did not recover from pain; This is a spontaneous report from a contactable consumer reported for herself. A 60-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via intramuscular, administered in Arm Left on 24Apr2021 (Lot Number: EW0170) at age of 60-year-old as single dose for covid-19 immunisation. The patient received 1st dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) administered in Arm Left on 02Apr2021 15:45 at age of 60-year-old (Lot Number: ER8732), for covid-19 immunisation, after the first dose, she was fine after 3 days of flu like symptoms. Medical history included Type II diabetes, onset date: 8 or more year ago (she was fine with blood glucose, she was on low carb keto diet) and known allergies: aspirin. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have COVID tested post vaccination and did not have COVID prior vaccination. Concomitant medications included metformin (METFORMIN); glimepiride (GLIMEPIRIDE). It was reported on 24Apr2021 21:00, After the second dose, she was waiting to recover from it but her arms did not recover from pain, she could not move her left arm upward and it was now painful to raise her left arm or reach her back. She could not raise her left arm until now and she had piercing pain when she moved it. It was difficult even to dress up. The piercing pain woke her up at night a lot of times.  She could not tie her hair and became so difficult to remove her clothes or put them on. She could not lean on it when she was sleeping and it woke her up when she accidently turn to the left. It was uncomfortable even if she was not leaning on it that she needed extra pillow under it. Seriousness criteria was reported as persistence/ significant disability incapability. The events required visiting to physician office. The patient had seen her doctor. No treatment was received for the events. The outcome of events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Madarosis
Clinical narrative: Lost her eyebrows hair; Hair started falling out.; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 07Mar2021(at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Patient received unspecified blood pressure medications within 2 weeks of vaccination. Patient had no known allergies to food, medication or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on an unknown date in 2021 as a single dose for COVID-19 immunisation. On 30Apr2021, the patient stated that she lost her eyebrows hair, looks as if she had cancer by eyes and also experienced hair started falling out. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event she lost her eyebrows hair, looks as if she had cancer by eyes and also experienced hair started falling out was not recovered at the time of this report.
Age: 12.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pyrexia
Clinical narrative: Fever; Headache; Nausea; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 12-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 05Jul2021 at 18:00 (at the age of 12-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 from an unknown date. The patient had no known allergies reported. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient did not receive any other medications within two weeks of the COVID vaccine. On 06Jul2021 at 08:00, the patient experienced fever, headache, nausea and fatigue that lasted for 3 days. The events resulted in doctor or other healthcare professional office/clinic visit.  Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever, headache, nausea and fatigue were resolved on 09Jul2021.   The lot number for BNT162b2 was not provided and will be requested during follow up.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia, Inappropriate schedule of product administration
Clinical narrative: extreme hair loss post vaccination; inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer (patient). A 46-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 15May2021 12:00 (at the age of 46-year-old) as single dose for COVID-19 immunisation. There were no medical history and concomitant medications. The patient had no known allergies. She had no covid prior vaccination. The patient did not receive any other vaccine in four weeks and any other medications in two weeks. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Left on 31Mar2021 10:30 (at the age of 46-year-old) as single dose for COVID-19 immunisation. The patient had inappropriate schedule of vaccine administered on 15May2021 12:00. The patient experienced extreme hair loss post vaccination since 01Jun2021 12:00. The AE resulted in Doctor or other healthcare professional office/clinic visit. Doctors had not found any other reason or source of hair loss. No treatment received for the hair loss. The patient had not tested Covid post vaccination. Outcome of the event hair loss was not recovered.  Information about the Lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Cough, Headache, Pyrexia
Clinical narrative: fever; headache; cough; This is a spontaneous report from a Pfizer sponsored program from a non-contactable consumer (patient). A female patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number and expiration date were not reported) via an unspecified route of administration on 13Jul2021 at single dose for covid-19 immunization. The patient medical history and concomitant medication were not reported. On an unspecified date, the patient was experiencing fever, headache, cough and asked was she eligible to get the 2nd dose of the vaccine or not. The outcome of events was unknown.      No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pyrexia
Clinical narrative: Fever and a sore throat; Fever and a sore throat; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (parent). A male patient of unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number and expiration date were not reported) via an unspecified route of administration on 16May2021 at single dose for covid-19 immunisation. The patient medical history and concomitant medication were not reported. On 12Jun2021, the patient got a fever and a sore throat, it only happened one day. The consumer (patient's mother) entire family including herself got their first and second dose of the Pfizer vaccine. The outcome of the events was recovered in Jun2021  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Eye movement disorder, Muscle spasms, Myalgia, Pain, Pain in extremity
Clinical narrative: Muscle ache; Severe cramps in my legs; Teeth ache in my jaw, a severe one teeth aching; My eyes ran, were oozing; Pain in arm/I could feel the pain in my arm; The caller states she has been in severe pain since Feb; This is a spontaneous report from a contactable consumer or other non hcp.    A 80-years-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 25Feb2021 02:30 as dose 1, single for covid-19 immunisation The patient medical history concomitant medications was not reported. It was Reported, the caller is a consumer reporting she received both doses Pfizer Covid 19 Vaccine. The caller received the first dose Pfizer Covid 19 Vaccine on 25Feb2021 at (Withheld) and the second dose Pfizer Covid 19 Vaccine was received on 18Mar2021 also at (withheld). The doses of the Pfizer Covid 19 Vaccine were received 21 days or so apart. The caller has had severe adverse effects after receiving the Pfizer Covid 19 Vaccine. The caller can barely use her legs, the legs are in severe pain. The caller was a person that walked and exercised, walked 3 miles a day. The caller can barely get around, and up and down in the morning is hell. The caller is so weak, and the legs hurt so bad. The other effect is the caller's eyes swelled up and ran sticky oozy stuff. The caller went to the dermatologist and was given cortisone and after 14-15 days that cleared up, it was white. The caller went to her doctor about the pain in her legs. The caller is taking Tramadol and Ibuprofen and they are not a lot of help. The doctor said it will run its course. the patient experienced pain in arm/i could feel the pain in my arm, the caller states she has been in severe pain since feb, muscle ache, severe cramps in my legs, teeth ache in my jaw, a severe one tooth aching, my eyes ran, were oozing on an unspecified date with outcome of unknown. Therapeutic measures were taken as a result of the caller states she has been in severe pain since feb (pain). Follow-up (16Jul2021): This is a Follow-up spontaneous report from a contactable consumer. This consumer (patient) reported information included. Follow up (16Jul2021): This is a follow up spontaneous report from a contactable consumer. This 80-year-old female consumer (patient) reported in response to telephonic follow-up activity which included Follow up (31Jul2021): This is a Follow-up spontaneous report from a contactable consumer.  This 80-year-old female consumer (patient) reported information included.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Teething
Clinical narrative: Muscle ache; Severe cramps in my legs; Teeth ache in my jaw, a severe one teeth aching; My eyes ran, were oozing; Pain in arm/I could feel the pain in my arm; The caller states she has been in severe pain since Feb; This is a spontaneous report from a contactable consumer or other non hcp.    A 80-years-old female patient received bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection (Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 25Feb2021 02:30 as dose 1, single for covid-19 immunisation The patient medical history concomitant medications was not reported. It was Reported, the caller is a consumer reporting she received both doses Pfizer Covid 19 Vaccine. The caller received the first dose Pfizer Covid 19 Vaccine on 25Feb2021 at (Withheld) and the second dose Pfizer Covid 19 Vaccine was received on 18Mar2021 also at (withheld). The doses of the Pfizer Covid 19 Vaccine were received 21 days or so apart. The caller has had severe adverse effects after receiving the Pfizer Covid 19 Vaccine. The caller can barely use her legs, the legs are in severe pain. The caller was a person that walked and exercised, walked 3 miles a day. The caller can barely get around, and up and down in the morning is hell. The caller is so weak, and the legs hurt so bad. The other effect is the caller's eyes swelled up and ran sticky oozy stuff. The caller went to the dermatologist and was given cortisone and after 14-15 days that cleared up, it was white. The caller went to her doctor about the pain in her legs. The caller is taking Tramadol and Ibuprofen and they are not a lot of help. The doctor said it will run its course. the patient experienced pain in arm/i could feel the pain in my arm, the caller states she has been in severe pain since feb, muscle ache, severe cramps in my legs, teeth ache in my jaw, a severe one tooth aching, my eyes ran, were oozing on an unspecified date with outcome of unknown. Therapeutic measures were taken as a result of the caller states she has been in severe pain since feb (pain). Follow-up (16Jul2021): This is a Follow-up spontaneous report from a contactable consumer. This consumer (patient) reported information included. Follow up (16Jul2021): This is a follow up spontaneous report from a contactable consumer. This 80-year-old female consumer (patient) reported in response to telephonic follow-up activity which included Follow up (31Jul2021): This is a Follow-up spontaneous report from a contactable consumer.  This 80-year-old female consumer (patient) reported information included.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Loss of personal independence in daily activities, Myalgia
Clinical narrative: right leg muscle sharp pain (lower & upper leg); knee joint pain moved to hip joint and then to lower back affecting getting up and walking.; knee joint pain moved to hip joint and then to lower back affecting getting up and walking.; affecting getting up and walking. Could not function as before. Almost beyond taking care of myself; This is a spontaneous report from a contactable consumer, the patient. A 80-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6202) via an unspecified route of administration in the left arm on 09Feb2021(at the age of 80-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1283) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Feb2021 at 21:00, the patient at night time experienced right leg muscle sharp pain (lower & upper leg), knee joint pain moved to hip joint and then to lower back affecting getting up and walking and could not function as before, almost beyond taking care of herself. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the adverse events and included treatment with multi collagen for joints. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event right leg muscle sharp pain( lower & upper leg), knee joint pain moved to hip joint and then to lower back affecting getting up and walking and could not function as before, almost beyond taking care of herself was unknown at the time of this report.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dysphonia, Oropharyngeal pain, Sputum discoloured
Clinical narrative: Phlegm (color brownish); Voice changing; Sore throat, near where tonsils would be, though they have been removed.; Excessive phlegm (light tan) that returned every 30m after coughing to expunge.; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on an unknown date in 12Jul2021 at 12:45 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as not applicable. It was reported that the patient had none known allergies. The patient did not receive any concomitant medications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Jul2021, the patient experienced sore throat, near where tonsils would be, though they have been removed. Excessive phlegm (light tan) that returned every 30m after coughing to expunge on 13Jul2021. On 14Jul2021, the patient reported laryngitis type symptoms included voice changing, throat sore, phlegm (color brownish) now only every 2 hours at the time of reporting. The patient reported no fever, no nausea and no fatigue. Therapeutic measures were taken as a result of the events which included NYQUIL on Wednesday and Thursday, MUCINEX on Friday. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore throat, phlegm, coughing, laryngitis and voice changing was not recovered at the time of this report.   The batch/lot numbers for BNT162b2 were not provided and will be requested during follow up.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram, Heart rate, Inappropriate schedule of product administration, Palpitations
Clinical narrative: heart racing event up to 130 bpm; Inappropriate schedule of vaccination as dose 1 took on 21may2021 and dose 2 took on 30May2021 outside the  window period; This is a spontaneous report from a contactable healthcare professional, the patient. A 43-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 30May2021 at 11:45 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. Medical history included gastroesophageal reflux disease(GERD), irritable bowel syndrome(lbs). The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN), ranitidine hydrochloride (ZANTAC), mefenamic acid (ADVIL), probiotic and womens vitamins; all from an unknown date and for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 21May2021 at 11:00 (at the age of 43-year-old) as a single dose for COVID-19 immunisation. On 18Jun2021, 3 weeks after her second vaccine she had a heart racing event up to 130 bpm. She went to general provider and had ekg. At that time she was at 120bpm. Since this time she had the same symptoms off and on and cannot exercise or exert herself without inducing more heart racing. She was  scheduled to see a cardiologist in the near future. It took her a long time to convince herself to get this vaccine and now she was regretting it. The event resulted in doctor or other healthcare professional office/clinic visit. On an unknown date, the patient underwent EKG and the result was 120 bpm. On 18Jun2021, the patient checked heart rate and the result was 130 bpm. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event heart racing event up to 130 bpm, she went to general provider and had ekg, at that time she was at 120bpm, since this time she had the same symptoms off and on and cannot exercise or exert herself without inducing more heart racing was not resolved at the time of this report.